TROG 13.01 (SAFRON II)

Primary sponsor: Trans Tasman Radiation Oncology Group (TROG)
Collaborating group: Australasian Lung Cancer Trials Group (ALTG)

Title

Stereotactic body radiotherapy in lung metastases from any non haematological primary cancer.

Summary

Stereotactic body radiotherapy (SBRT) is a new form of cancer radiotherapy treatment and there are two SABR techniques emerging in Australia; single session and multi session. This study will examine the safety of these two techniques used to treat metastatic disease to the lung, as determined by the various side effects, to determine which technique is the best to be used in Australia and New Zealand in the future

Final accrual 

90

Trial status

Closed to accrual 13 June 2018

Trial chairperson

A/Prof Shankar Siva, Peter MacCallum Cancer Centre, VIC

Trial contact

Kassandra Wagenfuehr
TROG Trial Coordinating Centre
Phone: +61 2 4014 3912
Email: SAFRONII@trog.com.au

Further information

TROG trial 13.01 on Australian Cancer Trials website

Trial resources for TROG members

TROG 13.01 member page